Resurgent Financial Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Buy
3,548
+106
+3% +$8.17K 0.09% 219
2025
Q4
$273K Buy
3,442
+596
+21% +$47K 0.14% 174
2025
Q3
$215K Buy
+2,846
New +$195K 0.11% 199
2024
Q2
Sell
-4,339
Closed -$346K 182
2024
Q1
$346K Buy
4,339
+1,352
+45% +$103K 0.18% 140
2023
Q4
$236K Sell
2,987
-35
-1% -$2.49K 0.14% 151
2023
Q3
$211K Buy
3,022
+21
+0.7% +$1.49K 0.14% 143
2023
Q2
$207K Sell
3,001
-67
-2% -$4.77K 0.14% 139
2023
Q1
$228K Sell
3,068
-2,039
-40% -$171K 0.15% 134
2022
Q4
$476K Sell
5,107
-6,150
-55% -$593K 0.25% 96
2022
Q3
$1.07M Buy
11,257
+6,282
+126% +$622K 0.72% 40
2022
Q2
$461K Sell
4,975
-1,307
-21% -$128K 0.3% 97
2022
Q1
$635K Buy
6,282
+3,095
+97% +$325K 0.39% 73
2021
Q4
$328K Buy
+3,187
New +$295K 0.26% 88

Other funds holding CVS

Resurgent Financial Advisors's CVS Position: Q1 2026 in Review

Resurgent Financial Advisors increased its CVS Health (CVS) stake by 3.1% in Q1 2026, buying an estimated $8.17K and bringing the position to 3,548 shares worth $255K. The position accounts for 0.09% of the portfolio, ranked #219.

Resurgent Financial Advisors first reported a position in CVS in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.07M in Q3 2022. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Resurgent Financial Advisors held 3,548 shares of CVS Health worth $255K as of Q1 2026.
  • Resurgent Financial Advisors bought 106 CVS Health shares in Q1 2026, an estimated $8.17K.
  • CVS Health made up 0.09% of Resurgent Financial Advisors's portfolio in Q1 2026, its #219 holding.
  • Resurgent Financial Advisors first reported a position in CVS Health in Q4 2021 and has held it in 13 quarters since.
  • Resurgent Financial Advisors's CVS Health position peaked at $1.07M in Q3 2022.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Resurgent Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.